Bayesian Capital Management, LP Biomarin Pharmaceutical Inc Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 10,400 shares of BMRN stock, worth $539,864. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,400
Previous 34,100
69.5%
Holding current value
$539,864
Previous $2.41 Million
76.31%
% of portfolio
0.1%
Previous 0.41%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
693Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$986 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$819 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$784 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$638 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.65B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...